Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Chemoattractant-mediated leukocyte trafficking enables HIV dissemination from the genital mucosa
Maud Deruaz, … , Thorsten R. Mempel, Andrew D. Luster
Maud Deruaz, … , Thorsten R. Mempel, Andrew D. Luster
Published April 6, 2017
Citation Information: JCI Insight. 2017;2(7):e88533. https://doi.org/10.1172/jci.insight.88533.
View: Text | PDF
Research Article AIDS/HIV Immunology

Chemoattractant-mediated leukocyte trafficking enables HIV dissemination from the genital mucosa

  • Text
  • PDF
Abstract

HIV vaginal transmission accounts for the majority of newly acquired heterosexual infections. However, the mechanism by which HIV spreads from the initial site of viral entry at the mucosal surface of the female genital tract to establish a systemic infection of lymphoid and peripheral tissues is not known. Once the virus exits the mucosa it rapidly spreads to all tissues, leading to CD4+ T cell depletion and the establishment of a viral reservoir that cannot be eliminated with current treatments. Understanding the molecular and cellular requirements for viral dissemination from the genital tract is therefore of great importance, as it could reveal new strategies to lengthen the window of opportunity to target the virus at its entry site in the mucosa where it is the most vulnerable and thus prevent systemic infection. Using HIV vaginal infection of humanized mice as a model of heterosexual transmission, we demonstrate that blocking the ability of leukocytes to respond to chemoattractants prevented HIV from leaving the female genital tract. Furthermore, blocking lymphocyte egress from lymph nodes prevented viremia and infection of the gut. Leukocyte trafficking therefore plays a major role in viral dissemination, and targeting the chemoattractant molecules involved can prevent the establishment of a systemic infection.

Authors

Maud Deruaz, Thomas T. Murooka, Sophina Ji, Marc A. Gavin, Vladimir D. Vrbanac, Judy Lieberman, Andrew M. Tager, Thorsten R. Mempel, Andrew D. Luster

×

Figure 1

HIV dissemination in humanized BLT mice following intravaginal (IVAG) infection.

Options: View larger image (or click on image) Download as PowerPoint
HIV dissemination in humanized BLT mice following intravaginal (IVAG) in...
BLT-NOD-scid (NS, plain symbols) and BLT-NOD-scid IL2Rγ–/– (NSG, crossed symbols) mice were sacrificed at different days postinfection (dpi) with 1 × 105 50% tissue culture infectious dose (TCID50) R5-tropic HIV strain JRCSF (HIVJRCSF) IVAG (n = 2–4 per time point). The presence of (A) viral RNA by RT-qPCR, (B) DNA by qPCR, or (C) infected T cells by p24+ flow cytometry, was analyzed in different tissues. Mice from which tissues were harvested on the same dpi are shown with the same color and each mouse within one color group is represented by a different symbol. Dotted line: mean value of tissue from 3 to 5 uninfected mice; gray box: ± 2 SD of mean value of uninfected mice. (D) Representative flow cytometry plots showing the percentage of HIV p24+ human CD4+ T cells in tissues of uninfected (left panels) and infected (middle panels) BLT-NS mice 10 dpi. Human CD8+ T cells (right panels) were used as negative controls. (E) HIV RNA in plasma detected by RT-qPCR. Dotted line: limit of sensitivity of the assay corresponding to 3 copies/μl HIV RNA (n = 2–7 per time point). (F) Ratio of human TNFA, CXCL9, and CXCL10 expression in CVT compared to iLNs at different dpi as measured by qPCR on tissue cDNA using a mean of 3 animals per group. CVT, cervico-vaginal tissue; LNs, lymph nodes; iLNs, iliac LNs; cLNs, cervical LNs; mLNs, mesenteric LNs.

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts